Loading clinical trials...
Loading clinical trials...
A Phase II Study of Ribavirin in Refractory of Relapsed Acute Myelocytic Leukemia M4 and M5 Subtypes
Conditions
Interventions
ribavirin
Locations
3
Canada
McMaster Hospital
Hamilton, Ontario, Canada
Maisonneuve-Rosemont Hospital
Montreal, Quebec, Canada
Jewish General Hospital
Montreal, Quebec, Canada
Start Date
April 1, 2007
Primary Completion Date
February 1, 2010
Completion Date
February 1, 2010
Last Updated
December 22, 2022
NCT00854646
NCT01188798
Lead Sponsor
Jewish General Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions